View |
|
DR-XY43810
|
Gliclazide
|
None
|
80 mg
|
Modified-Release Tablet
|
-
|
Lloyd Laboratories,Inc.
|
Philippines
|
-
|
14 October 2019
|
27 October 2024
|
View |
|
DR-XY43811
|
Irbesartan
|
Unbranded
|
300 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
08 July 2024
|
27 October 2029
|
View |
|
DR-XY43817
|
5% Dextrose in 0.9% Sodium Chloride
|
A.N.B
|
5% in 0.9 NaCl
|
Solution for I.V. Infusion
|
Rehydration Solution
|
A.N.B. Laboratories Co., Ltd.
|
Thailand
|
Initial (Variation)
|
10 June 2022
|
10 June 2027
|
View |
|
DR-XY43821
|
FLUMAZENIL
|
Anzenil
|
100 mcg/mL
|
Solution for Intravenous Infusion
|
Benzodiazepine-receptor Antagonist
|
Yichang Humanwell Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
11 August 2024
|
29 October 2029
|
View |
|
DR-XY43822
|
Clopidogrel (as bisulfate)
|
Acuvan
|
75mg
|
Film-Coated Tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
06 April 2020
|
29 October 2024
|
View |
|
DR-XY43827
|
Sodium Chloride + Potassium Chloride + Calcium Lactate Pentahydrate
|
Flo Sinus Care
|
1.544 g/83.16mg/ 63.13 mg
|
Powder For Reconstitution
|
Irrigating Solution
|
Interphil Laboratories, Inc.
|
Philippines
|
Renewal
|
16 March 2024
|
23 October 2029
|
View |
|
DR-XY43828
|
Potassium Chloride + Sodium Chloride
|
FLO CRS
|
180 mg/ 150 mg Sachets
|
Powder For Reconstitution
|
Nasal and Sinus Irrigation Decongestant
|
Interphil Laboratories, Inc.
|
Philippines
|
Renewal
|
27 March 2024
|
23 October 2029
|
View |
DR-XY43829_PI_01.pdf
|
DR-XY43829
|
Canagliflozin
|
Invokana
|
300 mg
|
Film-Coated Tablet
|
-
|
Janssen Cilag S.P.A.
|
Italy
|
Initial (from Monitored Release)
|
16 June 2022
|
23 October 2024
|
View |
|
DR-XY4383
|
Phenylpropanolamine Hydrochloride + Paracetamol
|
Nasathera
|
25 mg/ 325 mg
|
Capsule
|
Nasal Decongestant (Sympathomimetic)- Analgesic/Antipyretic
|
Morishita-Seggs Pharmaceuticals, Inc.
|
Philippines
|
Automatic Renewal
|
09 November 2022
|
30 October 2027
|
View |
DR-XY43830_PI_01.pdf
|
DR-XY43830
|
Canagliflozin
|
Invokana
|
100 mg
|
Film-Coated Tablet
|
Sodium-glucose co-transporter 2 (SGLT2) Inhibitor
|
Janssen Cilag S.P.A.
|
Italy
|
Initial (from Monitored Release)
|
16 June 2022
|
23 October 2024
|
View |
|
DR-XY43831
|
Desloratadine
|
Dezlotin
|
5mg
|
Film-Coated Tablet
|
-
|
Aurochem Laboratories
|
India
|
-
|
13 December 2019
|
27 October 2024
|
View |
|
DR-XY43838
|
Ambroxol Hydrochloride
|
AMBROFLEM
|
15mg
|
Lyophilized Powder For Injection (Im/Iv)
|
-
|
Hainan Weikang Pharmaceutical (Quin Shan) Co., Ltd.
|
China
|
-
|
17 September 2019
|
28 October 2024
|
View |
|
DR-XY43839
|
Ambroxol Hydrochloride
|
AMBROFLEM
|
30mg
|
Lyophilized Powder For Injection (Im/Iv)
|
-
|
Hainan Weikang Pharmaceutical (Quin Shan) Co., Ltd.
|
China
|
-
|
17 September 2019
|
28 October 2024
|
View |
|
DR-XY43840
|
Sterile Water For Injection
|
None
|
None
|
None
|
-
|
Grand Pharmaceutical (China) Co., Ltd.
|
China
|
-
|
24 October 2019
|
29 October 2024
|
View |
|
DR-XY43847 (For export Only )
|
Isoflurane
|
Isoking
|
1
|
Solution for Inhalation
|
-
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Automatic Renewal
|
14 October 2021
|
11 November 2026
|
View |
|
DR-XY43848
|
Iron (as Iron Sucrose)
|
FeMax
|
20 mg/mL
|
Solution for Injection (IV)
|
Anti-anemia
|
Gulf Pharmaceutical Industries ( Julphar )
|
UAE
|
Renewal
|
06 August 2024
|
30 October 2029
|
View |
|
DR-XY43849
|
(1) Rifampicin 200 mg/ 5 mL Suspension (Picinaf), (2) Isoniazid/Pyridoxine HCI 200 mg/20 mg per 5ml Syrup (Isowest),(3) Pyrazinamide 250 mg/5 ml Suspension (Zynaphar)
|
Trio-Kit
|
Refer to Generic name
|
Suspension; Syrup; Suspension
|
-
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
-
|
10 September 2020
|
10 November 2024
|
View |
|
DR-XY43850
|
Enalapril Maleate
|
Enafril
|
10 mg
|
Tablet
|
Angiotensin Converting Enzyme Inhibitor
|
Nanjing Baijingyu Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
12 August 2024
|
30 October 2029
|
View |
DR-XY43852_PI_01.pdf
|
DR-XY43852
|
Crizotinib
|
Xalkori
|
250mg
|
Capsule
|
-
|
Pfizer manufacturing Deutschland GmbH
|
Germany
|
Initial (from Monitored Release)
|
27 May 2022
|
30 October 2024
|
View |
DR-XY43853_PI_01.pdf
|
DR-XY43853
|
Crizotinib
|
Xalkori
|
200 mg
|
Capsule
|
-
|
Pfizer manufacturing Deutschland GmbH
|
Germany
|
Initial (from Monitored Release)
|
27 May 2022
|
30 October 2024
|